Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda X Y Chen

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 20, 2020
A New Safety Approach Allowing Reversible Control of CAR T Cell ResponsesAmanda X Y Chen, Imran G House, Paul A Beavis, et al.
Genome Biology and Evolution|September 9, 2016
The Genome as an Evolutionary TimepieceSimon Y W Ho, Amanda X Y Chen, Luana S F Lins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2020
Efficient CRISPR/Cas9 Gene Editing in Uncultured Naive Mouse T Cells for In Vivo StudiesSimone Nüssing, Imran G House, Conor J Kearney, et al.
Nature Communications|February 17, 2026
High efficiency CRISPR knock-in demonstrates that TCF1 is insufficient to reverse T cell exhaustionMaria N de Menezes, Amanda X Y Chen, Nihali Kulkarni, et al.
Nature Communications|May 29, 2021
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacyLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint BlockadeImran G House, Peter Savas, Junyun Lai, et al.
Nature Immunology|May 20, 2020
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunityJunyun Lai, Sherly Mardiana, Imran G House, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2020
IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid TumorsLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Nature Communications|November 2, 2023
A<sub>2A</sub>R eGFP reporter mouse enables elucidation of A<sub>2A</sub>R expression dynamics during anti-tumor immune responsesKirsten L Todd, Junyun Lai, Kevin Sek, et al.
Cell Reports|February 7, 2024
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunityImran G House, Emily B Derrick, Kevin Sek, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 20, 2020
A New Safety Approach Allowing Reversible Control of CAR T Cell ResponsesAmanda X Y Chen, Imran G House, Paul A Beavis, et al.
Genome Biology and Evolution|September 9, 2016
The Genome as an Evolutionary TimepieceSimon Y W Ho, Amanda X Y Chen, Luana S F Lins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2020
Efficient CRISPR/Cas9 Gene Editing in Uncultured Naive Mouse T Cells for In Vivo StudiesSimone Nüssing, Imran G House, Conor J Kearney, et al.
Nature Communications|February 17, 2026
High efficiency CRISPR knock-in demonstrates that TCF1 is insufficient to reverse T cell exhaustionMaria N de Menezes, Amanda X Y Chen, Nihali Kulkarni, et al.
Nature Communications|May 29, 2021
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacyLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint BlockadeImran G House, Peter Savas, Junyun Lai, et al.
Nature Immunology|May 20, 2020
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunityJunyun Lai, Sherly Mardiana, Imran G House, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2020
IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid TumorsLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Nature Communications|November 2, 2023
A<sub>2A</sub>R eGFP reporter mouse enables elucidation of A<sub>2A</sub>R expression dynamics during anti-tumor immune responsesKirsten L Todd, Junyun Lai, Kevin Sek, et al.
Cell Reports|February 7, 2024
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunityImran G House, Emily B Derrick, Kevin Sek, et al.
Pageof 2